{"count": 17, "results": [{"_id": "35146420", "pmid": 35146420, "pmcid": "PMC8818901", "title": "Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidemic rats", "journal": "Curr Res Pharmacol Drug Discov", "authors": ["Verma K", "Makwana S", "Paliwal S", "Paliwal V", "Jain S", "Paliwal S", "Sharma S"], "date": "2022-01-28T00:00:00Z", "doi": "10.1016/j.crphar.2022.100088", "meta_date_publication": "2022", "meta_volume": "3", "meta_issue": "", "meta_pages": "100088", "score": 50273.598, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ can be repurposed for the treatment of oxidative stress in @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@liver diseases@@@.", "citations": {"NLM": "Verma K, Makwana S, Paliwal S, Paliwal V, Jain S, Paliwal S, Sharma S. Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidemic rats Curr Res Pharmacol Drug Discov. 2022;3():100088. PMID: 35146420", "BibTeX": "@article{35146420, title={Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidemic rats}, author={Verma K and Makwana S and Paliwal S and Paliwal V and Jain S and Paliwal S and Sharma S}, journal={Curr Res Pharmacol Drug Discov}, volume={3}, pages={100088}}"}}, {"_id": "33424274", "pmid": 33424274, "pmcid": "PMC7783227", "title": "Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability", "journal": "Saudi Pharm J", "authors": ["Faris TM", "Harisa GI", "Alanazi FK", "Samy AM", "Nasr FA"], "date": "2020-12-01T00:00:00Z", "doi": "10.1016/j.jsps.2020.11.012", "meta_date_publication": "2020 Dec", "meta_volume": "28", "meta_issue": "12", "meta_pages": "1851-1867", "score": 50267.805, "text_hl": "These findings demonstrated that hepatic-targeted CSChSNPs delivering @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SV@@@ could potentially serve as a promising platform for @DISEASE_Carcinoma_Hepatocellular @DISEASE_MESH:D006528 @@@HCC@@@ and other @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@liver-related diseases@@@.", "citations": {"NLM": "Faris TM, Harisa GI, Alanazi FK, Samy AM, Nasr FA. Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability Saudi Pharm J. 2020 Dec;28(12):1851-1867. PMID: 33424274", "BibTeX": "@article{33424274, title={Developed simvastatin chitosan nanoparticles co-crosslinked with tripolyphosphate and chondroitin sulfate for ASGPR-mediated targeted HCC delivery with enhanced oral bioavailability}, author={Faris TM and Harisa GI and Alanazi FK and Samy AM and Nasr FA}, journal={Saudi Pharm J}, volume={28}, number={12}, pages={1851-1867}}"}}, {"_id": "33204591", "pmid": 33204591, "pmcid": "PMC7653246", "title": "Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature", "journal": "JIMD Rep", "authors": ["Yaplito-Lee J", "Pai G", "Hardikar W", "Hong KM", "Pitt J", "Marum J", "Amor DJ"], "date": "2020-08-18T00:00:00Z", "doi": "10.1002/jmd2.12158", "meta_date_publication": "2020 Nov", "meta_volume": "56", "meta_issue": "1", "meta_pages": "14-19", "score": 50259.613, "text_hl": "Plasma @CHEMICAL_Sterols @CHEMICAL_MESH:D013261 @@@sterol@@@ analysis and exome sequencing confirmed the diagnosis of @DISEASE_Lathosterolosis @DISEASE_MESH:C537880 @@@lathosterolosis@@@. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ treatment resulted in lowering of plasma @CHEMICAL_lathosterol @CHEMICAL_MESH:C001521 @@@lathosterol@@@ levels, improvement in transaminitis, and @DISEASE_Liver_Cirrhosis @DISEASE_MESH:D008103 @@@liver fibrosis@@@ grade, suggesting that children with this condition should be actively treated in order to prevent progression of @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@liver disease@@@.", "citations": {"NLM": "Yaplito-Lee J, Pai G, Hardikar W, Hong KM, Pitt J, Marum J, Amor DJ. Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature JIMD Rep. 2020 Nov;56(1):14-19. PMID: 33204591", "BibTeX": "@article{33204591, title={Successful treatment of lathosterolosis: A rare defect in cholesterol biosynthesis:A case report and review of literature}, author={Yaplito-Lee J and Pai G and Hardikar W and Hong KM and Pitt J and Marum J and Amor DJ}, journal={JIMD Rep}, volume={56}, number={1}, pages={14-19}}"}}, {"_id": "32681987", "pmid": 32681987, "title": "Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease.", "journal": "Nanomedicine", "authors": ["Hide D", "Gil M", "Andrade F", "Rafael D", "Raurell I", "Bravo M", "Barberá A", "Gracia-Sancho J", "Vargas V", "Augustin S", "Genescà J", "Schwartz S Jr", "Martell M"], "date": "2020-10-01T00:00:00Z", "doi": "10.1016/j.nano.2020.102267", "meta_date_publication": "2020 Oct", "meta_volume": "29", "meta_issue": "", "meta_pages": "102267", "score": 50258.3, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@chronic liver disease@@@.", "citations": {"NLM": "Hide D, Gil M, Andrade F, Rafael D, Raurell I, Bravo M, Barberá A, Gracia-Sancho J, Vargas V, Augustin S, Genescà J, Schwartz S Jr, Martell M. Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease. Nanomedicine. 2020 Oct;29():102267. PMID: 32681987", "BibTeX": "@article{32681987, title={Simvastatin-loaded polymeric micelles are more effective and less toxic than conventional statins in a pre-clinical model of advanced chronic liver disease.}, author={Hide D and Gil M and Andrade F and Rafael D and Raurell I and Bravo M and Barberá A and Gracia-Sancho J and Vargas V and Augustin S and Genescà J and Schwartz S Jr and Martell M}, journal={Nanomedicine}, volume={29}, pages={102267}}"}}, {"_id": "37896223", "pmid": 37896223, "title": "Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells.", "journal": "Pharmaceutics", "authors": ["Gil M", "Khouri L", "Raurell I", "Rafael D", "Andrade F", "Abasolo I", "Schwartz S Jr", "Martínez-Gómez M", "Salcedo MT", "Pericàs JM", "Hide D", "Wei M", "Metanis N", "Genescà J", "Martell M"], "date": "2023-10-14T00:00:00Z", "doi": "10.3390/pharmaceutics15102463", "meta_date_publication": "2023 Oct 14", "meta_volume": "15", "meta_issue": "10", "meta_pages": "", "score": 50252.066, "text_hl": "In this study, we developed functionalized polymeric micelles (FPMs) loaded with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ (FPM-Sim) as a drug delivery system to target liver sinusoidal endothelial cells (LSECs) for preserving liver function in @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@chronic liver disease@@@ (@<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@CLD@@@). ", "citations": {"NLM": "Gil M, Khouri L, Raurell I, Rafael D, Andrade F, Abasolo I, Schwartz S Jr, Martínez-Gómez M, Salcedo MT, Pericàs JM, Hide D, Wei M, Metanis N, Genescà J, Martell M. Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells. Pharmaceutics. 2023 Oct 14;15(10):. PMID: 37896223", "BibTeX": "@article{37896223, title={Optimization of Statin-Loaded Delivery Nanoparticles for Treating Chronic Liver Diseases by Targeting Liver Sinusoidal Endothelial Cells.}, author={Gil M and Khouri L and Raurell I and Rafael D and Andrade F and Abasolo I and Schwartz S Jr and Martínez-Gómez M and Salcedo MT and Pericàs JM and Hide D and Wei M and Metanis N and Genescà J and Martell M}, journal={Pharmaceutics}, volume={15}, number={10}}"}}, {"_id": "35811365", "pmid": 35811365, "pmcid": "PMC9271712", "title": "Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models", "journal": "Korean J Intern Med", "authors": ["Kang SH", "Yim HJ", "Hwang JW", "Kim MJ", "Lee YS", "Jung YK", "Yim H", "Kim BH", "Park HC", "Seo YS", "Kim JH", "Yeon JE", "Um SH", "Byun KS"], "date": "2022-07-01T00:00:00Z", "doi": "10.3904/kjim.2021.138", "meta_date_publication": "2022 Jul", "meta_volume": "37", "meta_issue": "4", "meta_pages": "745-756", "score": 50247.29, "text_hl": "This value increased to 8.44% after combined treatment with 5 muM @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and 50 muM @CHEMICAL_N_(2_cyclohexyloxy_4_nitrophenyl)methanesulfonamide @CHEMICAL_MESH:C080955 @@@NS-398@@@ a nd was highest at 27.3% after combination treatment with 10 muM @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and 50 muM @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@. ", "citations": {"NLM": "Kang SH, Yim HJ, Hwang JW, Kim MJ, Lee YS, Jung YK, Yim H, Kim BH, Park HC, Seo YS, Kim JH, Yeon JE, Um SH, Byun KS. Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models Korean J Intern Med. 2022 Jul;37(4):745-756. PMID: 35811365", "BibTeX": "@article{35811365, title={Improved anti-fibrotic effects by combined treatments of simvastatin and NS-398 in experimental liver fibrosis models}, author={Kang SH and Yim HJ and Hwang JW and Kim MJ and Lee YS and Jung YK and Yim H and Kim BH and Park HC and Seo YS and Kim JH and Yeon JE and Um SH and Byun KS}, journal={Korean J Intern Med}, volume={37}, number={4}, pages={745-756}}"}}, {"_id": "38128755", "pmid": 38128755, "title": "Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways.", "journal": "Life Sci", "authors": ["Salama YA", "Hassan HM", "El-Gayar AM", "Abdel-Rahman N"], "date": "2024-01-15T00:00:00Z", "doi": "10.1016/j.lfs.2023.122349", "meta_date_publication": "2024 Jan 15", "meta_volume": "337", "meta_issue": "", "meta_pages": "122349", "score": 50241.703, "text_hl": "The three treatment groups ameliorated @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@hepatic dysfunction@@@ and altered parameters of @CHEMICAL_Sphingolipids @CHEMICAL_MESH:D013107 @@@sphingolipid@@@ and pyroptosis pathways. ", "citations": {"NLM": "Salama YA, Hassan HM, El-Gayar AM, Abdel-Rahman N. Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways. Life Sci. 2024 Jan 15;337():122349. PMID: 38128755", "BibTeX": "@article{38128755, title={Combined quercetin and simvastatin attenuate hepatic fibrosis in rats by modulating SphK1/NLRP3 pathways.}, author={Salama YA and Hassan HM and El-Gayar AM and Abdel-Rahman N}, journal={Life Sci}, volume={337}, pages={122349}}"}}, {"_id": "8668280", "pmid": 8668280, "title": "[Clinically manifest liver lesions during use of simvastatin].", "journal": "Ned Tijdschr Geneeskd", "authors": ["Koornstra JJ", "Ottervanger JP", "Fehmers MC", "Stricker BH"], "date": "1996-04-13T00:00:00Z", "meta_date_publication": "1996 Apr 13", "meta_volume": "140", "meta_issue": "15", "meta_pages": "846-8", "score": 50077.33, "text_hl": "[Clinically manifest @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@liver lesions@@@ during use of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@].", "citations": {"NLM": "Koornstra JJ, Ottervanger JP, Fehmers MC, Stricker BH. [Clinically manifest liver lesions during use of simvastatin]. Ned Tijdschr Geneeskd. 1996 Apr 13;140(15):846-8. PMID: 8668280", "BibTeX": "@article{8668280, title={[Clinically manifest liver lesions during use of simvastatin].}, author={Koornstra JJ and Ottervanger JP and Fehmers MC and Stricker BH}, journal={Ned Tijdschr Geneeskd}, volume={140}, number={15}, pages={846-8}}"}}, {"_id": "29707200", "pmid": 29707200, "pmcid": "PMC5883384", "title": "Evaluation of portal pressure by doppler ultrasound in patients with cirrhosis before and after simvastatin administration - a randomized controlled trial", "journal": "F1000Res", "authors": ["Elwan N", "Salah R", "Hamisa M", "Shady E", "Hawash N", "Abd-Elsalam S"], "date": "2018-03-01T00:00:00Z", "doi": "10.12688/f1000research.13915.1", "meta_date_publication": "2018", "meta_volume": "7", "meta_issue": "", "meta_pages": "256", "score": 50067.395, "text_hl": " In para 4, the authors write that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ can be used safely in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@chronic liver disease@@@. ", "citations": {"NLM": "Elwan N, Salah R, Hamisa M, Shady E, Hawash N, Abd-Elsalam S. Evaluation of portal pressure by doppler ultrasound in patients with cirrhosis before and after simvastatin administration - a randomized controlled trial F1000Res. 2018;7():256. PMID: 29707200", "BibTeX": "@article{29707200, title={Evaluation of portal pressure by doppler ultrasound in patients with cirrhosis before and after simvastatin administration - a randomized controlled trial}, author={Elwan N and Salah R and Hamisa M and Shady E and Hawash N and Abd-Elsalam S}, journal={F1000Res}, volume={7}, pages={256}}"}}, {"_id": "30417426", "pmid": 30417426, "title": "Ameliorative effects of autophagy inducer, simvastatin on alcohol-induced liver disease in a rat model.", "journal": "J Cell Biochem", "authors": ["Atef MM", "Hafez YM", "Alshenawy HA", "Emam MN"], "date": "2019-05-01T00:00:00Z", "doi": "10.1002/jcb.28042", "meta_date_publication": "2019 May", "meta_volume": "120", "meta_issue": "5", "meta_pages": "7679-7688", "score": 50060.227, "text_hl": "Ameliorative effects of autophagy inducer, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @CHEMICAL_Alcohols @CHEMICAL_MESH:D000438 @@@alcohol@@@-induced @<m>DISEASE_Liver_Diseases</m> @DISEASE_MESH:D008107 @@@liver disease@@@ in a @SPECIES_10116 @@@rat@@@ model.", "citations": {"NLM": "Atef MM, Hafez YM, Alshenawy HA, Emam MN. Ameliorative effects of autophagy inducer, simvastatin on alcohol-induced liver disease in a rat model. J Cell Biochem. 2019 May;120(5):7679-7688. PMID: 30417426", "BibTeX": "@article{30417426, title={Ameliorative effects of autophagy inducer, simvastatin on alcohol-induced liver disease in a rat model.}, author={Atef MM and Hafez YM and Alshenawy HA and Emam MN}, journal={J Cell Biochem}, volume={120}, number={5}, pages={7679-7688}}"}}]}